|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Ethanol results in increased expression of ACTA2 protein]; Betulinic Acid inhibits the reaction [Thioacetamide results in increased expression of ACTA2] |
CTD |
PMID:21172400 PMID:22285267 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
increases phosphorylation multiple interactions |
ISO |
Betulinic Acid results in increased phosphorylation of AKT1 protein 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Betulinic Acid results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:16077934 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bak1 |
BCL2-antagonist/killer 1 |
increases expression multiple interactions |
ISO |
Betulinic Acid results in increased expression of BAK1 protein [Betulinic Acid co-treated with Oxygen deficiency] results in increased expression of BAK1 protein |
CTD |
PMID:33181113 |
|
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine co-treated with Betulinic Acid analog] results in increased activity of BAX protein; CA 074 methyl ester inhibits the reaction [[2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine co-treated with Betulinic Acid analog] results in increased activity of BAX protein] |
CTD |
PMID:23000516 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
Betulinic Acid results in decreased expression of BCL2 protein [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein |
CTD |
PMID:30136359 PMID:33181113 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions increases expression decreases expression decreases response to substance |
ISO |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Betulinic Acid results in increased expression of BIRC5]; Betulinic Acid promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein]; Erlotinib Hydrochloride inhibits the reaction [Betulinic Acid results in decreased expression of BIRC5 protein] BIRC5 protein results in decreased susceptibility to Betulinic Acid |
CTD |
PMID:16077934 PMID:26540049 PMID:30136359 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
increases expression decreases expression |
ISO |
Betulinic Acid results in increased expression of BMI1 protein Betulinic Acid results in decreased expression of BMI1 protein |
CTD |
PMID:33157086 |
|
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases activity multiple interactions |
ISO |
Betulinic Acid analog results in decreased activity of CA9 protein Betulinic Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] |
CTD |
PMID:26540049 PMID:29454615 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity increases cleavage |
ISO |
2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [Betulinic Acid analog results in increased cleavage of CASP3 protein]; Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased cleavage of CASP3 protein]; Betulinic Acid inhibits the reaction [Bortezomib results in increased cleavage of CASP3 protein]; CA 074 methyl ester inhibits the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [Betulinic Acid analog results in increased cleavage of CASP3 protein]]; VDAC1 protein inhibits the reaction [Betulinic Acid results in increased expression of CASP3 protein modified form] Betulinic Acid analog results in increased activity of CASP3 protein; Betulinic Acid results in increased activity of CASP3 protein Betulinic Acid analog results in increased cleavage of CASP3 protein; Betulinic Acid results in increased cleavage of CASP3 protein |
CTD |
PMID:22260869 PMID:23000516 PMID:26772157 PMID:28578903 PMID:29454615 PMID:30136359 PMID:30482226 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases activity |
ISO |
VDAC1 protein inhibits the reaction [Betulinic Acid results in increased expression of CASP7 protein modified form] Betulinic Acid results in increased activity of CASP7 protein |
CTD |
PMID:22260869 PMID:30136359 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases activity |
ISO |
Betulinic Acid results in increased activity of CASP8 protein |
CTD |
PMID:26772157 PMID:29454615 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Betulinic Acid analog results in increased activity of CASP9 protein; Betulinic Acid results in increased activity of CASP9 protein |
CTD |
PMID:26772157 PMID:29454615 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Dimethylnitrosamine results in decreased activity of CAT protein] |
CTD |
PMID:34472159 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
Betulinic Acid results in decreased expression of CCNB1 protein |
CTD |
PMID:33181113 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
Betulinic Acid analog results in decreased expression of CCND1 protein; Betulinic Acid results in decreased expression of CCND1 protein [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of CCND1 protein |
CTD |
PMID:28254521 PMID:33181113 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
multiple interactions |
ISO |
Betulinic Acid promotes the reaction [Erlotinib Hydrochloride results in decreased expression of CDK6 protein]; Betulinic Acid promotes the reaction [Gefitinib results in decreased expression of CDK6 protein] |
CTD |
PMID:30136359 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
ISO |
Betulinic Acid analog results in increased expression of CDKN1A protein |
CTD |
PMID:28254521 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions decreases expression |
ISO |
Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of CEBPB protein alternative form]; Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of CEBPB protein alternative form] Betulinic Acid results in decreased expression of CEBPB protein modified form |
CTD |
PMID:30482226 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
[Betulinic Acid co-treated with Erlotinib Hydrochloride] results in decreased expression of CTNNB1 protein; [Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of CTNNB1 protein Betulinic Acid results in decreased expression of CTNNB1 protein |
CTD |
PMID:30136359 PMID:33181113 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Ctsk |
cathepsin K |
multiple interactions |
ISO |
Betulinic Acid inhibits the reaction [TNFSF11 protein results in increased secretion of CTSK protein] |
CTD |
PMID:24463094 |
|
NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of DDIT3 protein]; Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of DDIT3 protein] |
CTD |
PMID:30482226 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions increases phosphorylation |
ISO |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Betulinic Acid results in increased phosphorylation of EGFR protein]; Betulinic Acid promotes the reaction [Gefitinib results in decreased expression of EGFR protein modified form] |
CTD |
PMID:16077934 PMID:30136359 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases phosphorylation multiple interactions |
ISO |
Betulinic Acid results in increased phosphorylation of GSK3B protein [Betulinic Acid co-treated with Oxygen deficiency] results in increased phosphorylation of GSK3B protein |
CTD |
PMID:33181113 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
decreases expression multiple interactions |
ISO |
Betulinic Acid results in decreased expression of HIF1A protein [Betulinic Acid co-treated with Oxygen deficiency] affects the expression of HIF1A protein |
CTD |
PMID:26540049 PMID:33181113 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hk2 |
hexokinase 2 |
multiple interactions |
ISO |
[VDAC1 protein results in decreased susceptibility to Betulinic Acid] which results in increased expression of HK2 protein |
CTD |
PMID:30136359 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Dimethylnitrosamine results in increased expression of IL6 protein] |
CTD |
PMID:34472159 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression |
ISO |
Erlotinib Hydrochloride promotes the reaction [Betulinic Acid results in increased expression of MAP1LC3B protein modified form] |
CTD |
PMID:30136359 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation |
ISO |
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Betulinic Acid results in increased phosphorylation of MAPK1 protein]; [Betulinic Acid co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:16077934 PMID:33181113 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation multiple interactions |
ISO |
Betulinic Acid results in increased phosphorylation of MAPK3 protein 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Betulinic Acid results in increased phosphorylation of MAPK3 protein]; [Betulinic Acid co-treated with Oxygen deficiency] results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:16077934 PMID:33181113 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mir24-2 |
microRNA 24-2 |
multiple interactions affects response to substance |
ISO |
MIR24-2 mRNA affects the susceptibility to [Betulinic Acid co-treated with Gemcitabine] MIR24-2 mRNA affects the susceptibility to Betulinic Acid |
CTD |
PMID:25841339 |
|
NCBI chr19:23,954,683...23,954,790
Ensembl chr19:23,954,683...23,954,790
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP ISO |
Betulinic Acid inhibits the reaction [Ethanol results in increased expression of MMP2 protein] Betulinic Acid inhibits the reaction [TNFSF11 protein results in increased secretion of MMP2 protein] Betulinic Acid affects the reaction [TGFB1 protein affects the expression of and affects the secretion of MMP2 protein] |
CTD |
PMID:21172400 PMID:24463094 PMID:28578903 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
Betulinic Acid inhibits the reaction [TNFSF11 protein results in increased secretion of MMP9 protein] |
CTD |
PMID:24463094 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[Betulinic Acid co-treated with Oxygen deficiency] results in decreased expression of MYC protein |
CTD |
PMID:33181113 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Ethanol results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:21172400 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nos1 |
nitric oxide synthase 1 |
multiple interactions |
ISO |
Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of NOS1 protein] |
CTD |
PMID:30482226 |
|
NCBI chr12:38,615,111...38,795,492
Ensembl chr12:38,626,714...38,710,945
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage increases expression multiple interactions |
ISO |
Betulinic Acid results in increased cleavage of PARP1 protein Betulinic Acid results in increased expression of PARP1 protein modified form [Betulinic Acid co-treated with Oxygen] results in increased cleavage of PARP1 protein; Betulinic Acid promotes the reaction [Gefitinib results in increased cleavage of PARP1 protein] |
CTD |
PMID:26540049 PMID:30136359 PMID:33181113 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions decreases expression |
EXP ISO |
Betulinic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PCNA protein] Betulinic Acid analog results in decreased expression of PCNA protein |
CTD |
PMID:28254521 PMID:34541749 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pla2g2a |
phospholipase A2 group IIA |
affects binding |
ISO |
Betulinic Acid binds to PLA2G2A protein |
CTD |
PMID:29391000 |
|
NCBI chr 5:151,076,442...151,079,019
Ensembl chr 5:151,076,442...151,079,014
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of PTGS2 protein] |
CTD |
PMID:34541749 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Pthlh |
parathyroid hormone-like hormone |
multiple interactions decreases expression decreases secretion decreases response to substance |
ISO |
Betulinic Acid inhibits the reaction [PTHLH protein results in increased expression of TNFSF11 protein] Betulinic Acid results in decreased expression of PTHLH mRNA Betulinic Acid results in decreased secretion of PTHLH protein Betulinic Acid results in decreased susceptibility to PTHLH protein |
CTD |
PMID:24463094 |
|
NCBI chr 4:180,188,792...180,199,847
Ensembl chr 4:180,188,792...180,199,847
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases expression multiple interactions |
ISO |
Betulinic Acid results in decreased expression of RB1 protein modified form Betulinic Acid promotes the reaction [Erlotinib Hydrochloride results in decreased expression of RB1 protein modified form]; Betulinic Acid promotes the reaction [Gefitinib results in decreased expression of RB1 protein modified form]; Erlotinib Hydrochloride promotes the reaction [Betulinic Acid results in decreased expression of RB1 protein modified form]; Gefitinib promotes the reaction [Betulinic Acid results in decreased expression of RB1 protein modified form] |
CTD |
PMID:30136359 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Ethanol results in increased phosphorylation of RELA protein] |
CTD |
PMID:21172400 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Ethanol results in increased phosphorylation of SMAD3 protein] |
CTD |
PMID:21172400 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
ISO |
[Betulinic Acid co-treated with Erlotinib Hydrochloride] results in decreased expression of STAT3 protein modified form |
CTD |
PMID:30136359 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP ISO |
Betulinic Acid inhibits the reaction [Ethanol results in increased expression of TGFB1 protein] Betulinic Acid affects the reaction [TGFB1 protein affects the expression of and affects the secretion of MMP2 protein] |
CTD |
PMID:21172400 PMID:28578903 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Ethanol results in increased expression of TIMP1 protein] |
CTD |
PMID:21172400 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Ethanol results in increased expression of TIMP2 protein] |
CTD |
PMID:21172400 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
Betulinic Acid inhibits the reaction [Dimethylnitrosamine results in increased expression of TNF protein] |
CTD |
PMID:34472159 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf11 |
TNF superfamily member 11 |
multiple interactions decreases response to substance |
ISO |
Betulinic Acid inhibits the reaction [PTHLH protein results in increased expression of TNFSF11 protein] Betulinic Acid results in decreased susceptibility to TNFSF11 protein Betulinic Acid inhibits the reaction [TNFSF11 protein results in increased secretion of CTSK protein]; Betulinic Acid inhibits the reaction [TNFSF11 protein results in increased secretion of MMP2 protein]; Betulinic Acid inhibits the reaction [TNFSF11 protein results in increased secretion of MMP9 protein] |
CTD |
PMID:24463094 |
|
NCBI chr15:53,673,850...53,705,325
Ensembl chr15:53,673,877...53,705,445
|
|
G |
Top1 |
DNA topoisomerase I |
decreases activity |
ISO |
Betulinic Acid results in decreased activity of TOP1 protein |
CTD |
PMID:10860928 |
|
NCBI chr 3:149,293,469...149,376,618
Ensembl chr 3:149,293,403...149,376,623
|
|
G |
Top2a |
DNA topoisomerase II alpha |
decreases activity |
ISO |
Betulinic Acid results in decreased activity of TOP2A protein |
CTD |
PMID:10860928 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tp53 |
tumor protein p53 |
increases expression multiple interactions |
ISO |
Betulinic Acid results in increased expression of TP53 protein [Betulinic Acid co-treated with Oxygen deficiency] results in increased expression of TP53 protein |
CTD |
PMID:33181113 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trib3 |
tribbles pseudokinase 3 |
multiple interactions |
ISO |
Betulinic Acid inhibits the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of TRIB3 protein]; Betulinic Acid inhibits the reaction [Bortezomib results in increased expression of TRIB3 protein] |
CTD |
PMID:30482226 |
|
NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497
|
|
G |
Tyms |
thymidylate synthetase |
multiple interactions decreases expression |
ISO |
Betulinic Acid promotes the reaction [Erlotinib Hydrochloride results in decreased expression of TYMS protein]; Betulinic Acid promotes the reaction [Gefitinib results in decreased expression of TYMS protein]; Erlotinib Hydrochloride promotes the reaction [Betulinic Acid results in decreased expression of TYMS protein]; Gefitinib promotes the reaction [Betulinic Acid results in decreased expression of TYMS protein] |
CTD |
PMID:30136359 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Vdac1 |
voltage-dependent anion channel 1 |
decreases response to substance multiple interactions increases expression |
ISO |
VDAC1 protein results in decreased susceptibility to Betulinic Acid [VDAC1 protein results in decreased susceptibility to Betulinic Acid] which results in increased expression of HK2 protein; VDAC1 protein inhibits the reaction [Betulinic Acid results in increased expression of CASP3 protein modified form]; VDAC1 protein inhibits the reaction [Betulinic Acid results in increased expression of CASP7 protein modified form] Betulinic Acid results in increased expression of VDAC1 protein |
CTD |
PMID:30136359 |
|
NCBI chr10:36,532,306...36,559,642
Ensembl chr10:36,532,244...36,559,640
|
|